# Humanity

The app that helps you live healthier for longer

- Canonical URL: https://wefunder.com/humanity
- Entity ID: wefunder:company:138526
- Last updated: 2026-06-08T05:01:23Z
- Generated at: 2026-06-08T08:57:14Z

## Quick facts
- Cutting-edge health navigation app, AI powered, to monitor your aging and guides you to slow it down
- Founders have scaled consumer apps to 1 billion users & exited for hundreds of millions of $$$
- Highly Rated: 4.8 Stars with over 4,500 reviews on the Apple App Store
- Market leading metrics: 74% WAU/MAU, 42% DAU/MAU and 55% retention after 12 weeks for premium users
- 10x conversion to premium subscription rate compared to industry average (Up to 55% for over 55s)
- Proven behavior change with 15% median increase in movement after sign up (18% increase if BMI > 30)
- Advanced partnership discussions with several of the world's largest companies in health & wellness
- Backed by top investors: Seedcamp, OneWay Ventures, co-founders of Calm, SweatCoin & One Medical etc

## Active fundraises
- wefunder:fundraise:90267: 4(a)(6) successful (USD)
- wefunder:fundraise:90268: 4(a)(6) successful (USD)

## Story
Humanity is an app that enables you to monitor your rate of aging and then guides you to slow it down.The founders have already launched, scaled and exited B2C and B2B platforms that reached over 1 billion users and exited for hundreds of millions of dollars. They have deep expertise in consumer tech, scaling subscription businesses, viral growth, developing a high-performance and value-centric culture, fundraising and selling businesses.Aging is the loss of core body functionality over time and it significantly shortens and decreases the quality of all our lives and those of our loved ones. The founders experienced their loved ones dying from chronic diseases and felt completely helpless. They built Humanity so that all of us would no longer be helpless.Aging damage is the leading cause of disease, loss of quality of life, and then death.Most services focus on abstract measures that are too downstream from the body’s core functions that actually positively affect healthspan. The user is left with their main question unanswered. That question is: “Am I getting healthier?”There's also a lack of ongoing monitoring of core aging biomarkers.Most Biological Age tests are too expensive and one-off, and thus not effective for judging the effect of preventive actions.Ultimately, there was no clear, concrete feedback loop to understand what’s working to slow your aging and thus increase your core health. Humanity is now that clear feedback loop.Our system is the one of the first platforms that uses AI and machine learning to understand what actions are working to slow aging and thus keep people healthier for longer, based on what's working for other Humanity users like them.Humanity has a 10x higher conversion to premium rate compared to industry average. Proving that people are quite happy to pay for a service that actually keeps them young and healthy.These future financial projections are not guaranteed.In 2023, we focused on refining its product-market fit in preparation for commercial scale in 2024. The current performance indicates a positive return on ad spend (ROAS) based on the initial purchase, along with a notably high conversion rate to premium subscription.The conservative estimate for customer lifetime value (LTV) stands at $75, and there are plans to launch a Pro product featuring blood analysis at a higher price early next year. The customer acquisition cost (CAC) is approximately $40, and there are expectations of improved results with upcoming tests on Web Flow.The platform boasts 20,000 monthly active users (MAU), with a monthly growth rate of 10%, demonstrating robust retention rates (41% after 12 weeks, 73% for Premium users) and high engagement (66% weekly active users to monthly active users). Despite being pre-revenue, there is a 12% conversion to Premium, generating $16,000 monthly.Looking ahead to 2024, we forecast a significant uplift with over $3 million in annual recurring revenue (ARR), driven by the launch of the Pro product, increased user growth, and B2B partnerships. The current monthly recurring revenue (MRR) is in the range of $15,000 to $20,000, contributing to an ARR of $220,000.The projected figures for 2024 include $3.92 million in bookings and $1.94 million in revenues. Humanity's focus has been on developing a top-tier product with metrics that surpass leading apps in the category by 3-10 times. In 2024, efforts will be intensified to increase revenue.Forward-looking projections are not guaranteed.Humanity is  #1 in the App Store for healthspan, longevity, and AI health. It has a 4.8 star Apple App Store rating with over 4,500 reviews and is attracting strategic partnership interest from some of the largest health companies in the world.By tracking key aging biomarkers against what actions people are taking daily, Humanity uses machine learning and aging models trained on real-world outcomes to recommend personalized actions based on what’s working for other Humanity users like them.This proven behavior change of 15.4% jumps to 18% if the individual's BMI is higher than 30.Digital Health: 18.6% CAGR, from $211.0B in 2022 to $809.2B in 2030AI Health: 37.5% CAGR, from $15.4B in 2022 to 208.2B in 2030Mobile Health Market: 39% CAGR from $58.2B to $123.1B+ in 2030 5% market penetration alone is worth $6.2BThese future financial projections are not guaranteed.The company has already attracted a world-class team, including world-renowned Science and Business advisors and investors in HealthTech and Longevity. Key ClientsWe are in the process of securing strategic partnerships to launch B2B Pilots with:- One of the world's largest hardware and software companies- One of the largest health and wellness retailers- One of the largest health and fitness appsKey PartnersWe have strategic partnerships with the following partners:- Gero.ai: A physics enabled biotechnology company and aging model specialist- Illumina: For DNA methylation monitoring and genotyping- Eurofins: For DNA methylation testing and one of the largest lab groups on the planet- Chronomics: For DNA methylation analysisCurrent & Future ProjectsPriority 1: Viral Growth - Iterate on a viral growth engine that drives organic, exponential growth. Building on the key expertise the founders learned with their social network and dating app.Priority 2: B2B Dashboard for Humanity Enterprise - Build an analytics dashboard to aggregate Humanity health data for teams.Priority 3: Blood Analysis - Adding a Premium Pro subscription level which includes blood analysis, based on the blood aging model we submitted for publication in a Nature publication, which is currently in peer-review.Priority 4: App Refinements - To include improvements to Compare, Actions, Guidance and launching new offerings to increase engagementPriority 5: Blood & Genetics Monitoring - Add subscription options to take cutting edge aging tests based on blood biomarkers and DNA Methylation samples on a periodic basis, directly from HumanityJoin us, and together we can help all humanity live a healthier life for longer.

## FAQ
1. **What's your MRR/ARR?**
   - Hi Micah! MRR is around $15-20k and ARR $220k. We forecast $3.92M bookings and $1.94M revenues in 2024. Our focus thus far has not been revenue, but instead - creating a best-in-class product with proven behavior change and high retention, engagement and conversion, which is what we have achieved, with metrics 3-10x higher than the leading apps in our category. We're also introducing a number of improvements to the app over the coming weeks and months that will make the app experience more en...
2. **Would like to see financial statements before investing in this business.**
   - Sure, no problem. As mentioned below, these will be added once the CPA review is completed.
3. **I find your business concept interesting and would like to seriously consider an investment. That said, as others have noted, I would not do so without reviewing financials and a budget — especially since the investment vehicle is a SAFE. For context on my question, I am a pro...**
   - Thanks Michael. Happy to schedule a call if you'd like to dig in more, as sounds like you are much like many of our existing investors, so appreciate the feedback. As mentioned below, we are currently undertaking a CPA review as part of the Wefunder process and thus our financials will be added to the page once complete. As mentioned below, I can add a summary of our financial forecasts and some of unit economics also, at the same time.
4. **As a Lifestyle Medicine Consultant, I know there is a significant market and can see the potential success of a service/App such as this. I also agree that financials, forecast and more details about ARR are necessary before I would consider investing.**
   - Thanks Aoife! It was great to have you join us on the webinar also, and we appreciated your question on there! Hopefully the panelists did a good job of answering it :) See below for more info on our ARR and more info on some of our plans. Our financials will be added to the page once the CPA review has been completed and we can add our forecasts for the next 5 years also.
5. **What is your cash on hand and monthly burn rate? Wishing all the best!**
   - We have around half a million at bank and a normalised burn of around $70k ecxluding new investment coming in. And thanks! We raised more in the first week on the platform than any other company, and blown away by the support on how humanity is helping people! Some exciting announcements to come.. :)

## Team
- Peter Ward (Co-Founder and CEO)
- Michael Geer (Co-Founder and CSO)
- Peter Joshi (Chief Science Officer)
- Marko Ivanovski (Chief Technology Officer)
- Dr Timothy Hill (Product and Clinical Lead)
- Anna Orzlowska (HR Manager)

## Recent posts
- Last 16 hours before we close (2024-04-29T11:38:02Z)
- Webinar Recording + new hire + closing soon (Monday!) (2024-04-26T15:08:13Z)
- Last Webinar: How Old Is Your Body? With the president of lifespan.io, and national news correspondent. (2024-04-19T17:32:54Z)
- Over $2.75M Raised + We’re Growing! (2024-04-15T10:27:00Z)
- Investor Update - Some Highlights (2024-02-21T18:35:28Z)
- Exciting Milestone Achieved: We’ve Surpassed our Initial Funding Goal! (2023-12-30T20:02:08Z)
- Watch Webinar Replay: Exploring Biomarkers for Tomorrow's Health (2023-12-13T17:49:36Z)
- You're Invited: Exploring Biomarkers for Tomorrow's Health - Viit Health x Humanity Webinar (2023-12-07T00:15:16Z)
- GenAI, Health, and alliances (2023-12-05T18:42:02Z)
- Humanity named "Hottest HealthTech Startup" (2023-11-21T11:50:54Z)
- New Feature Release: Streaks, a new way to create positive habits! (2023-11-01T20:05:59Z)
- Humanity Nominated in the The Europas Tech Startup Awards 2023🚀 (2023-10-28T20:42:54Z)
- Most Raised on Wefunder in Just 3 Days! (2023-10-27T21:15:53Z)
- Our Raise is Now Live! (2023-10-24T23:34:15Z)
- Health and Longevity Webinar Recording (2023-10-20T22:10:12Z)

## Q&A
- Q: I find your business concept interesting and would like to seriously consider an investment. That said, as others have noted, I would not do so without reviewing financials and a budget — especially since the investment vehicle is a SAFE. For context on my question, I am a professional private equity and venture investor and 3x successful founder/ceo and have never invested in a crowd sourced financing, which makes me a bit curious about why you are pursuing this approach in lieu of institutional investors? Very open to considering if additional information is available and if not I wouldn’t pursue it and advise less experienced people to be very cautious.
  - A: Thanks Michael. Happy to schedule a call if you'd like to dig in more, as sounds like you are much like many of our existing investors, so appreciate the feedback. As mentioned below, we are currently undertaking a CPA review as part of the Wefunder process and thus our financials will be added to the page once complete. As mentioned below, I can add a summary of our financial forecasts and some of unit economics also, at the same time.
- Q: Hi Peter, Can you please provide some context how you plan to grow rev from $220k to $130M in five years? Is it through only subscription? At a 5% conversion rate (which is really high) and an $80 average annual customer value (my arbitrary guess), you'd need 1.63m paid and 33m total users to get that 1.63m. Is that realistic? Thank you and congratulations.
  - A: Hi Jeremy, Thanks for your questions! The freemium subscription flywheel, once you get both the unit economics and viral coefficient right, is what propels the business model at that level of scale. For example, when my awesome co-founder Michael Geer was running operations at AnchorFree, they successfully grew subscription revenues to $300m a year, by scaling up both b2c and b2b channels in this way. We intend to do the same and thus a combination of B2B traction with enterprises (especially once our platform becomes self serve) and by getting the social engagement and one-to-many feedback loops humming, we will be able to unlock that level of growth and more. The only question is how long it takes to reach that inflection point. We are getting closer all the time, and that's the main focus for early 2024. I hope that helps!
- Q: Thanks, Michael. A couple of follow-up questions, please: 1. How much are you aiming to raise through this crowdfunding round? And when is the deadline to invest? 2. You note that you are the "World's #1 Health and Longevity App." What is this ranking based on? Thanks!
  - A: Hi Brian, thanks for your questions! 1. We have already reached our first fundraising goal, which is $500k via Wefunder and c. $2.5m in total on the same terms. We've decided to keep the option open for people to invest for the coming weeks as we see it as a great way to foster brand advocacy and a key part of our mission to extend the impact beyond the privileged few. The likely cap will be a few hundred k more. 2. This is based on the number of ratings and reviews and rating level in the App Store. If you search for "Longevity" apps in the App Store, you will see that we are by far the leading app in the category. I hope that helps!
- Q: Good morning, Congrats on your success so far. I have a couple of questions: 1. You mention a "freemium" business model. What are the specific prices for the higher-level plans? Are they monthly or annual subscriptions? 2. I see the mention of biomarkers (assuming these include things like blood pressure, cholesterol, heart rate), but you also mention digital markers? Can you give some detail about these digital markers and how they go into determining a user's age? Thanks very much!
  - A: Thanks for the questions and kind words, Brian! 1. We currently are live with a Premium subscription which has an average cost of $50 per year and only sold annually. We will be going live with a higher Pro subscription level (includes blood result analysis from our new blood model just published in Nature!) that will most likely retail at an average of $120 per year and again sold annually. 2. The 4 main components of Biological Age measure are the "digital markers" of movement pattern and heart rate pattern (both live in the app now already) and we will then release blood analyte analysis in Pro (details above) and then next year we will release DNA Methylation analysis (most likely included in Pioneer subscription plan).
- Q: where can try your app? i looked in google appstore,it is not on there
  - A: Hi Deng, We plan to launch on Android next year. Best, Pete
- Q: Hi again, Peter & Humanity Team. Congrats on all your success so far. I, along with members of my Doriot Venture Club community, am interested in investing but have some questions. Thanks in advance for your responses! 1) Can you give more details on your B2B business model? I.e. Use cases, benefits, and pricing? 2) Great to see the list of notable investors. How many of them are participating in this round? 3) From your filing records, it looks like you raised $2.15M+ in Sept 2023, but only had $218k+ cash on hand 3 months later in Dec 2023. Is this correct? If so, what were these funds used for? 4) From an outsider’s perspective, the health & fitness space looks incredibly crowded. What’s your “competitive edge” and what would make a user decide to use Humanity instead of (or in addition to) other products like Whoop, Oura, or Apple Watch/Health? Thank you!
  - A: For the benefit of others, I can answer your questions above: 1) We are offering Premium and Pro (includes blood aging) licences, Humanity for Teams / Enterprise, and have Biological Age APIs. Each offering has a number of features and benefits which can be customised to the client and use case need. Multiple use cases: Offer to customers to inprove their health over time or between visits, adding aging measures to other health markers, reducing absenteesim and increasing team wellbeing and productivity, enhancing diagnostic offerings, creating more stickiness, retention and upgrade benefits or reasons to subscribe on third party platforms / adding more premium benefits to existing offerings. The list goes on. Pricing is on a per user fee depending on offering with discounts on volume etc. 2. Over 30 of them. 3. We did a rolling close on this round as had a number of angel investors and funds that wanted to come in over the past few months. Funds have been invested mainly in R&D activities including the Blood Aging model which is now successfully published in Nature. We now have runway until the end of 2024 but this will continually extend as we scale up revenues this year. 4. It is. Most apps and devices are focused on fitness or specific niches like meditation. Humanity is based on scientifically basked models for measuring your biological age and rate of aging, combined with a best-in-class UI/UX that has proven behaviour change and market leading engagement, retention and conversion metrics. We are agnostic to wearable and actually complement / amplify the value of wearables including the Apple Watch, Oura, Whoop and other devices. We are also by far the leading longevity app on the app store by number of reviews and ratings and by various external measures. What also differentiates us is our proven track record, investment backing, science advisory board, team, metrics and positioning. Watch this space, as we scale up and prove this out.
  - A: Hi Dan, apologies - I only just saw your questions and appreciate it's now too late. Happy to jump on a call if you'd like to revisit. Just noted that your summary compared us to hardware devices which we are not competing against. Let me know if you'd still like to set up a call.
- Q: Hi, one more queation. Are there machine learning opportunities (aka ai) to provide additional value with so many users? Thx
  - A: Hi Jeremy, Great question! Yes of course. We see generative AI playing an increasingly bigger role in the app personalization experience in iterations to come. Watch this space!..
- Q: Do you find Apple (Health and Watch) to be a direct competitor? For the genotyping and DNA methylation profiling, is this done via 3rd party lab? What is the cost to users? Does Humanity have a way for users to input any health data they have to get a tailored experience based on that information? Example: Someone inputs they have a certain disease that affects their liver and wants to improve their health but especially their liver health.
  - A: Hi Randon, Thanks for the questions.. We see Apple (Health and Watch) to be enablers and for Apple to be a strong partner as we scale. There is always competitive risk but based on our perspective, our approach and offering is highly complimentary to Apple's strategy as Humanity drives more engagement (and purchases) of Apple products and showcases their technology. Genotyping and DNA methylation profiling will be offered as a premium package we are dubbing "Pioneer". Details are still to be finalised as it's not the current priority but it will likely involve partnership with 3rd party labs and other key players in the ecosystem. The cost is yet to be determined but we have modelled it out to be competitively priced to attract as much adoption as possible. In regards to your last questions, it technically could but this is not the focus for now. We are primarily focused on the ostensibly healthy population as a wellness product, getting to "consumer-grade" for the mainstream marker. However, our intention is to become more "clinical-grade" in future as we demonstrate the impact of our offering in broader use cases to reduce disease risk in the first instance. I hope that helps answer your questions!
- Q: Hello! I, along with a group of other investors, are interested in potentially investing in your company. Would you be available to set up a call this week to discuss historical financials and key SaaS metrics? We want to make sure we hit our Q4'23 investment goal, so we are hoping to decide on the company we want to move forward with within a few weeks.
  - A: Hi Aryana! Thanks for your message. I'd be happy to schedule a call. I'm pretty stacked this week as in Taipei and Lisbon next week but will ping you my calendar via LinkedIn and hopefully can find a time to chat late next week. I can also ping you if I find myself free out of hours and in front of my computer, which is likely! :)
- Q: Greetings Humanity Team, When can you share the reviewed financials for the latest closed period/ year ?
  - A: Hi Atul, As mentioned below to Michael and Guillermo, look out for these being added when our CPA review has been finalized. Thanks, Pete
- Q: I saw Michael Baker already asking this question, but where can I take a look at your financials? Aside from that, do you have some insights into your MAU and user growth rate?
  - A: Hi Guillermo, as I mentioned to Michael - these will be added once the CPA review is finalised, so keep an eye out for that. Apologies for my slow reply! I'm in Taipei this week as Humanity won a business pitch competition and lots of opportunities to make a positive impact in this region! We've been working to get our Enterprise product ready to go with a large strategic partner and closing our first B2B deal on our Biological Age API, while at the same time we had the largest community round on Wefunder last week! Also, if you are using the app, we got a very cool Streaks feature launched last week, which is already driving engagement even higher. I figured I'll use your question to provide some context that may be useful to others asking and reviewing the questions also: - In the beginning of 2023 we pulled back on all marketing to work more on product market fit, which has paid off well. We have found PMF now and are just starting to market again but only ROAS positive (on first purchase not LTV). - LTV is conservatively estimated around $75, but need to see our annual cohorts renewals in the future before we get a true number on this - we will be launching our Pro product including blood analysis at a higher price point in December - CAC is around $40 and we'll be testing Web Flow soon where we expect this to be even better - MAU is growing and currently at 20k users per month, with a 10% monthly growth rate, which is a positive signal as we cut all marketing early in the year and is testament to our very high retention (currently 41% after 12 weeks, 73% for Premium users after 12 weeks - much higher than we ever saw in our previous companies) and Engagement (66% WAU/MAU - Streaks will raise this even higher). - It is fair to say we are still "pre-revenue" but have proven so far very high conversion to Premium (12%) and making about $16k per month at the moment. We forecast a big uplift next year with over $3M ARR thanks to the launch of Pro and scaling up of user growth from social capabilities (people are really digging growing their circles and its having a positive effect on referrals), and from B2B partnerships. - Perhaps the one we are most proud of is sustained healthy behavior change (15.4% on average and even higher 18% in the cohort of users with a BMI of 30 or higher) So with product market fit starting to take hold on B2C and B2B about to launch with major partners, we are excited to use the community round funds and a few new strategic angels (like co-founder of Match.com) to continue these trends and power us to a big priced round end of next year. It's great to have so many of our customers get behind us on this campaign and we've been touched by all the messages in the "What People Say" section when they invest. Hopefully, we can count you as one of them. :)
- Q: As a Lifestyle Medicine Consultant, I know there is a significant market and can see the potential success of a service/App such as this. I also agree that financials, forecast and more details about ARR are necessary before I would consider investing.
  - A: Thanks Aoife! It was great to have you join us on the webinar also, and we appreciated your question on there! Hopefully the panelists did a good job of answering it :) See below for more info on our ARR and more info on some of our plans. Our financials will be added to the page once the CPA review has been completed and we can add our forecasts for the next 5 years also.
- Q: Would like to see financial statements before investing in this business.
  - A: Sure, no problem. As mentioned below, these will be added once the CPA review is completed.
- Q: What's your MRR/ARR?
  - A: Hi Micah! MRR is around $15-20k and ARR $220k. We forecast $3.92M bookings and $1.94M revenues in 2024. Our focus thus far has not been revenue, but instead - creating a best-in-class product with proven behavior change and high retention, engagement and conversion, which is what we have achieved, with metrics 3-10x higher than the leading apps in our category. We're also introducing a number of improvements to the app over the coming weeks and months that will make the app experience more engaging and impactful. Revenue will become a much bigger focus in 2024. We are launching our premium pro offering in the next couple of months, which includes blood analysis, which will coincide with a groundbreaking announcement on how we have furthered the science on making predicting aging more accurate and accessible to the mainstream. In addition, we are also in the process of launching a number of B2B pilots with some of the world's largest health & wellness companies via our Humanity Enterprise, and B2B API offerings. Announcements on that soon.
- Q: Hello, I sent an email from johnathanddunn@gmail.com. I wanted to make sure it made it over, thanks.
  - A: Hi Jonathan, sorry for not getting back to you sooner. I checked and this is the only message I can see - did you want to ask a specific question? Thanks!